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Enterobacter cloacae is an emerging clinical pathogen that may be responsible for nosocomial infections.
Management of these infections is often difficult, owing to the high frequency of strains that are resistant to
disinfectants and antimicrobial agents in the clinical setting. Multidrug efflux pumps, especially those belong-
ing to the resistance-nodulation-division family, play a major role as a mechanism of antimicrobial resistance
in gram-negative pathogens. In the present study, we cloned and sequenced the genes encoding an AcrAcB-
TolC-like efflux pump from an E. cloacae clinical isolate (isolate EcDC64) showing a broad antibiotic resistance
profile. Sequence analysis showed that the acrR, acrA, acrB, and tolC genes encode proteins that display 79.8%,
84%, 88%, and 82% amino acid identities with the respective homologues of Enterobacter aerogenes and are
arranged in a similar pattern. Deletion of the acrA gene to yield an AcrA-deficient EcDC64 mutant (EcacrA)
showed the involvement of AcrAB-TolC in multidrug resistance in E. cloacae. However, experiments with an
efflux pump inhibitor suggested that additional efflux systems also play a role in antibiotic resistance.
Investigation of several unrelated isolates of E. cloacae by PCR analysis revealed that the AcrAB system is
apparently ubiquitous in this species.
Multidrug efflux pumps, especially those belonging to the
resistance-nodulation-division family, play a major role in es-
tablishing the “intrinsic or acquired” resistance of gram-nega-
tive bacteria to a wide range of toxic compounds, including
antibiotics (20).
A well-studied example is the AcrAB-TolC multidrug resis-
tance (MDR) tripartite pump system of Escherichia coli, which
confers resistance to a wide variety of lipophilic and amphiphilic
compounds, including dyes, detergents, and antimicrobial agents
such as ethidium bromide, crystal violet, sodium dodecyl sulfate,
bile acids, tetracycline, chloramphenicol, fluoroquinolones, -lac-
tams, erythromycin, and fusidic acid (17, 18). The presence of
similar systems has been reported for other members of Entero-
bacteriaceae (2, 9, 11, 12, 14, 15, 16, 21, 28).
The species of Enterobacter that most commonly cause nos-
ocomial infections are E. cloacae and E. aerogenes (24). The
existence of an acrB-like gene (11) has previously been iden-
tified in E. cloacae, although none of the components of the
efflux pump have been cloned.
The objectives of the present study were (i) to characterize
the genes encoding the AcrAB-TolC-like efflux pump of E.
cloacae and (ii) to determine the involvement of this efflux
pump in MDR in E. cloacae. The clinical strain used in the
study was an MDR strain of E. cloacae (EcDC64) which over-
expressed the AcrAB system and also overexpressed the chro-
mosomal ampC gene and exhibited a drastic reduction of
ompC gene expression.
(These results were presented in part at the 45th Inter-
science Conference on Antimicrobial Agents and Chemother-
apy [2a].)
MATERIALS AND METHODS
Bacterial strains and growth media. The bacterial strains used in the study are
listed in Table 1. Enterobacter cloacae clinical isolate EcDC64 was isolated from
a patient admitted to the intensive care unit of the Juan Canalejo Hospital (La
Corun˜a, NW Spain). The bacterial isolate was identified by a MicroScan Walk-
away (Dade Behring, Barcelona, Spain), and the identification was confirmed by
API 20E (bioMe´rieux, Marcy l’Etoile, France). Escherichia coli TG1 strain was
used for cloning procedures. All strains used in the study were maintained at
80°C in 15% (vol/vol) glycerol for cryoprotection until use. The strains were
grown on MacConkey agar plates (Becton, Dickinson and Company, NJ), in
Luria-Bertani (LB) broth, or on LB agar in the presence of 25 g of kana-
mycin/ml or 20 g of chloramphenicol/ml when required.
Susceptibility testing. Antibiotic susceptibility was determined by the follow-
ing three different methods, depending on the antimicrobial availability.
The MICs of the following antibiotics were determined by Etest (AB Biodisk,
Solna, Sweden) following the manufacturer’s criteria: ampicillin, penicillin,
amoxicillin-clavulanic acid, piperacillin, cephalothin, cefoxitin, cefuroxime, cefta-
zidime, aztreonam, cefotaxime, imipenem, meropenem, oxacillin, erythromycin,
clindamycin, tetracycline, chloramphenicol, tobramycin, gentamicin, amikacin,
ciprofloxacin, tigecycline, linezolid, and trimethoprim-sulfamethoxazole.
Susceptibility to the following antibiotics were determined by the standard disk
diffusion method (Becton, Dickinson and Company, NJ) on Mueller-Hinton
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agar: telithromycin, fusidic acid, novobiocin, nalidixic acid, rifampin, and nor-
floxacin.
The broth microdilution method (19) was used for detergents and dyes, so-
dium dodecyl sulfate, sodium cholate, sodium deoxycholate, acriflavine (Sigma-
Aldrich, St. Louis, MO), ethidium bromide, Triton X-100 (AppliChem GmbH,
Darmstadt, Germany), and crystal violet (Merck, Darmstadt, Germany). The
inoculum of E. cloacae cultures consisted of 5  105 CFU/ml, and the plates were
incubated for 16 to 20 h at 37°C. As the end point, the lowest concentration of
the compound that completely inhibited growth was recorded as the MIC.
The MICs of all antimicrobial agents, but not of the detergents and dyes (see
Tables 4 and 5), were also determined with the efflux pump inhibitor Phe-Arg-
-naphthylamide (PAN; Sigma-Aldrich, St. Louis, MO) at a final concentration
of 20 g/ml.
AmpC overexpression. To demonstrate the involvement of AmpC expression
in the -lactam resistance of the EcDC64 isolate, -lactam MICs were also
determined in the presence of 100 g/ml of cloxacillin. A plasmid construct
named pAP-1 (Table 1), which consisted of the ampD gene from E. coli cloned
into the pBGS18 plasmid, was also used. EcDC64 was electroporated with
pAP-1, transformants were selected in 25 g/ml of kanamycin, and the -lactam
MICs were determined and compared to those of EcDC64 carrying the empty
vector.
PCR amplification and sequencing of acrR, acrA, acrB, and tolC efflux pump
genes. Genomic DNA from EcDC64 was extracted from overnight cultures at
37°C by use of the MasterPure genomic DNA purification kit (EPICENTRE
Biotechnologies, Madison, WI). The oligonucleotides used to clone efflux pump
genes are listed in Table 2. Oligonucleotides were designed on the basis of the
previously reported nucleotide sequence of the E. aerogenes AcrAB-TolC (21)
(accession numbers AJ306389 and AJ306390) and the recently released Enter-
obacter sp. strain 638 complete genome (accession number CP000653). PCR was
performed with the extracted genomic DNA in 50 l of a mixture containing 50
ng of DNA template, 300 nM of each primer, 200 M of each deoxynucleoside
triphosphate, 1.5 mM MgCl2, 5 l of the polymerase buffer, and 2.6 U of Expand
high-fidelity enzyme (Roche Diagnostics GmbH; Mannheim, Germany). After
an initial denaturation step of 2 min at 94°C, amplification was performed over
25 cycles consisting of 15 s at 94°C, 30 s at the hybridization temperature (60°C,
55°C, 48°C, and 45°C for acrA, acrB, tolC, and acrR genes, respectively), and 1
min at 72°C for elongation, followed by a final extension step of 7 min at 72°C.
The PCR product was purified by a HighPure PCR product purification kit
(Roche Diagnostics GmbH; Mannheim, Germany) and then cloned into the
pCR2.1-TOPO TA cloning vector according to the manufacturer’s instructions
(Invitrogen Corporation, CA). Sequencing was carried out with a Taq DyeDeoxi-
Terminator cycle sequencing kit in an automatic DNA sequencer (377 ABI-
Prism; Perkin-Elmer). Each product was sequenced on both strands.
Disposition of each of the gene of the operon (acrR, acrA, and acrB) was
achieved by individual PCR products overlapping each other through the use of
the indicated oligonucleotides (Table 2) (data not shown).
Nucleotide and amino acid sequence analysis was carried out by use of the
following programs: ExPASy Proteomics Tools (http://www.ch.embnet.org
/software/LALIGN_form.html) and BLAST (http://www.ncbi.nlm.nih.gov
/BLAST/).
Construction of the acrA gene mutant. Disruption of the acrA gene in EcDC64
was performed by the method described by Datsenko and Wanner (6) with some
modifications. The Red helper plasmid pKOBEG (gift from J. M. Ghigo) (4)
(Table 1) is a low-copy-number plasmid that contains a gene for chloramphenicol
resistance, a temperature-sensitive origin of replication, and the Red system,
which includes three genes that express an exonuclease and the  and  functions
of phage . Plasmid pKOBEG (Table 1) was introduced into EcDC64 by heat
shock, and transformants were selected on LB agar with chloramphenicol (20
g/ml) after incubation for 24 h at 30°C. One transformant carrying the Red
helper plasmid was made electrocompetent. A selectable kanamycin resistance
gene was amplified by PCR from genomic DNA obtained from E. coli MC4100
(a gift from J. M. Ghigo) by use of primers that included 5 extensions with
homology for the acrA locus, i.e., acrAKm-F(forward) and acrAKm-R (reverse)
in Table 2. The PCR product was used to disrupt the acrA gene of
EcDC64(pKOBEG) by electroporation. Electroporation (25 F, 200 	, 2.5 kV)
of the EcDC64 electrocompetent strain was carried out according to the man-
ufacturer’s instructions (Bio-Rad Laboratories, Madrid, Spain) with 50 l of cells
and 1 g of purified and dialyzed (0.025-m nitrocellulose filters; Millipore,
Billerica, MA) PCR product. Shocked cells were added to 1 ml of LB broth,
incubated for 1 h at 30°C, spread onto LB agar with kanamycin (25 g/ml), and
then incubated at 30°C for 24 h. The Ec
acrA::Km mutant strain was then grown
on LB agar with kanamycin (25 g/ml) at 43°C for 24 h and incubated overnight
on LB agar with kanamycin (25 g/ml) and LB agar with chloramphenicol (20
g/ml) at 30°C to test for the loss of the helper plasmid.
To confirm the acrA deletion, a PCR assay with oligonucleotides (Table 2) that
hybridize in the acrA gene was done. As expected, a band of 1,450 nucleotides
(nt) was obtained by PCR, owing to the replacement of the acrA gene (1,194 nt)
with the kanamycin resistance gene (1,450 nt).
Construction of pAP-2 and pAP-3 vectors. For pAP-2 construction (Table 1),
two oligonucleotide primers (Table 2) were designed from the acrA sequence of
E. aerogenes to amplify, by PCR, the acrA gene from EcDC64. The amplified
DNA was purified, digested with EcoRV and HindIII, and then ligated (rapid
DNA ligation kit; Roche Diagnostics GmbH, Mannheim, Germany) into a sim-
ilarly digested expression pACYC184 vector under the control of the CTX-M-14
gene promoter. The CTX-M-14 gene promoter was first amplified with the pctx
oligonucleotides (Table 2), designed from position 1502 to position 1740 of the
sequence with EMBL database accession no. AF252622 from an E. coli clinical
isolate harboring the blaCTX-M-14 gene, and then cloned into the pACYC184
vector. The accuracy of the construct was checked by restriction analysis. The
recombinant plasmid (pAP-2) was then introduced into the Ec
AcrA competent
cells for complementation studies.
For pAP-3 construction (Table 1), the full acrR gene was amplified with
TABLE 1. Bacterial strains and plasmids used in the present study
Strain or plasmid Features (resistance markera) Source orreference
Strains
EcDC64 Multiresistant E. cloacae clinical strain isolated from a patient admitted to
our hospital
This study
Ec
acrA EcDC64 with acrA gene knockout This study
Ec
acrA(pAP-2) Ec
AcrA transformed with pAP-2 This study
Ec
acrA(pACYC184) Ec
AcrA transformed with pACYC184 This study
EcDC64(pAP-3) EcDC64 transformed with pAP-3 This study
EcDC64(pBGS18) EcDC64 transformed with pBGS18 This study
E. cloacae Jc 194 Carbapenem-susceptible strain used as reference strain in RT-PCR
experiments
This study
Plasmids
pBGS18 Cloning vector (kanamycin) 26
pACYC184 Cloning vector (chloramphenicol and tetracycline) 3, 22
pKOBEG Cloning vector (chloramphenicol) 4
pAP-1 (pBGS18-ampD) ampD gene from E. coli cloned into pBGS18 (kanamycin) This study
pAP-2 (pACYC184-acrA) acrA gene from EcDC64 isolate cloned into pACYC184 (chloramphenicol) This study
pAP-3 (pBGS18-acrR) acrR gene from E. aerogenes cloned into pBGS18 (kanamycin) This study
a Resistance markers for plasmids are shown in parentheses.
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specific oligonucleotides acrR-F and acrR-R (Table 2). The amplified fragment
of 650 bp was then digested with BamHI/EcoRI and ligated to the pBGS18
plasmid (26) under the control of the above-mentioned CTX-M-14 gene pro-
moter. The accuracy of the construct was checked by restriction analysis. The
recombinant plasmid (pAP-3) was then introduced into the EcDC64 competent
cells for antimicrobial susceptibility studies.
Real-time RT-PCR. Real-time reverse transcription-PCR (RT-PCR) was car-
ried out to determine the expression levels of the ompC and ompF porin genes
as well as of the tripartite efflux component, acrA. In all cases, the expression
levels were normalized to the rpoB housekeeping gene coding for the RNA
polymerase beta subunit. Primers designed from sequences with accession num-
bers AJ316540, AJ316539, EF627524, and AJ854260 from the ompF, ompC,
acrA, and rpoB genes, respectively, were used. Total RNA was isolated with
TRIzol reagent (Invitrogen Corporation, CA) according to the manufacturer’s
instructions and treated with RNase-free DNase I (Invitrogen Corporation, CA).
The concentration of RNA was determined spectrophotometrically. RNA (1 g)
was reverse transcribed into single-stranded cDNA by use of a Transcriptor
first-strand cDNA synthesis kit (Roche Diagnostics GmbH, Mannheim, Ger-
many), according to the manufacturer’s instructions. The cDNAs were quantified
by real-time PCR amplification with specific primers (Table 2) by use of a Light
Cycler 480 SYBR green I master kit and a Light Cycler 480 instrument (both
from Roche Diagnostics GmbH, Mannheim, Germany) with an initial incubation
of 95°C for 10 min followed by 45 cycles of 10 s at 95°C, 20 s at 60°C, and 10 s
at 72°C. The expression levels were standardized relative to the transcription
levels of rpoB (a housekeeping gene) for each isolate.
Detection of the acrA gene in several E. cloacae isolates. To determine whether
the AcrAB-TolC efflux pump is widespread among clinical isolates of E. cloacae,
a PCR assay was carried out to detect the acrA gene in different E. cloacae
isolates. Six genotypically different E. cloacae isolates (repetitive extragenic pal-
indromic-PCR tested), which showed different antibiotic susceptibility patterns
and which had been collected in the hospital during the previous 5 years, were
used. The reactions were carried out with a 50-l volume of a reaction mixture
containing 1.5 mM of MgCl2, 200 M of each deoxynucleoside triphosphate, 300
nM of each primer, 50 ng of chromosomal DNA, 5 l of the polymerase buffer,
and 2.5 U of Taq polymerase. The primers of the acrA-coding region, acrA-F and
acrA-R (Table 2), were used. Amplification reactions were submitted to the
following program: initial denaturation (10 min at 94°C) followed by 30 cycles of
denaturation (2 min at 94°C), annealing (1 min at 45°C), and extension (1 min at
72°C), with a single extension cycle of 10 min at 72°C.
Nucleotide sequence accession numbers. The nucleotide sequence data in the
study will appear in the EMBL/GenBank/DDBJ nucleotide sequence database.
The accession numbers are as follows: EF627524 for the acrR, acrA, and acrB
genes and AM287288 for the tolC gene.
RESULTS AND DISCUSSION
Cloning, sequencing, and analysis of the AcrAB-TolC efflux
pump genes of E. cloacae EcDC64. Enterobacter cloacae
EcDC64 was a clinical isolate which showed an antibiotic mul-
tiresistance profile (see Table 4).
The acrR, acrA, acrB, and tolC genes from EcDC64 were
amplified by high-fidelity PCR, cloned into the pCR2.1-TOPO
TABLE 2. Oligonucleotides used in the present study
Function Primer Gene Procedure Sequence (533)b
Cloning acrA-F acrA Cloning aagatatcATGAACAAAAACAGAGGGTTAACG
acrA-R acrA Cloning aaaagcttTTAAGACTTGGTTTGTTCAGACTG
acrB-F acrB Cloning ATGCCTAATTTCTTTATCGATCGC
acrB-Ra acrB Cloning RTGRTGRTCNACNGGRTGRTT
tolC-F tolC Cloning ATGCAAATGAAGAAA
tolC-R tolC Cloning TTAATGACGGAACGGATT
acrR-F acrR from E. aerogenes Cloning aaggatccATGGCACGAAAAACCAAACAA
CAGG
acrR-R acrR from E. aerogenes Cloning aagaattcTCAGGCCATGACCTCAGAGC
pctx-F promoter CTX-M-14 Cloning aaaggatccCCATCAATAAAATTGAG
pctx-R promoter CTX-M-14 Cloning aagatatcCTCAAACTCCCAATACG
acrAKm-F acrA Knockout GGCGTCGTGACGCTCAAATCCGAACCTCT
CCAGATGACAACAGAACTACCGGGCCG
CACCAAAGCCACGTTGTGTCTCAA
acrAKm-R acrA Knockout TGAAGCTACTTCCTGAGCCTTGACCTGCG
CGCCAGGACGAACTTTTTGCAAACCAGT
AATGCGCTGAGGTCTGCCTCGTG
Expression studies
(RT-PCR)
rpoB-Fa rpoB RT-PCR CAGCCGCGAYCAGGTTGACTACA
rpoB-R rpoB RT-PCR GACGCACCGCAGGATACCACCTG
ompC-F ompC RT-PCR AGGTTAACGATCAACTGACCGG
ompC-R ompC RT-PCR AAATTTCAGACCGGCGAACGCC
ompF-F ompF RT-PCR AGTGGGAATATAACTTCCAGGG
ompF-R ompF RT-PCR TGCGTCACCGAATTTCAGGCC
acrART-F acrA RT-PCR GATTATGATTCTGCCTTGGCCG
acrART-R acrA RT-PCR CAATGCGACCGCTGATAGGGG
Operon assembly aefA-Fc aefA from E. cloacae Amplification of the acrR-acrA
intergenic region
GTACATCGCGTTCTGCACGCG
acrA2-Rc acrA from E. cloacae Amplification of the acrR-acrA
intergenic region
TGCCTTGACATCACCGCCTTC
acrA3-Fd acrA from E. cloacae Amplification of the acrAB
intergenic region
CGACAAACAACAAGCGTCGGC
acrB2-Rd acrB from E. cloacae Amplification of the acrAB
intergenic region
ATGATGATTATGGCGATCACCC
a Oligonucleotide degenerated where R is A or G; N is A, C, G, or T; and Y is C or T.
b Lowercase and italic nucleotides indicate restriction sites for cloning.
c Oligonucleotides used for amplification, cloning, and sequencing of the acrR gene and the acrR-acrA intergenic region of the operon from E. cloacae EcDC64. F,
forward; R, reverse.
d Oligonucleotides used for amplification, cloning, and sequencing of the acrAB intergenic region of the operon from E. cloacae EcDC64. F, forward; R, reverse.
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TA cloning vector, and sequenced. Sequence analysis showed
that genes acrR, acrA, acrB, and tolC from E. cloacae, which
were 654, 1,194, 3,147, and 1,485 bp long, encoded proteins of
218, 397, 1,048, and 494 amino acids, respectively. AcrR, AcrA,
AcrB, and TolC proteins from EcDC64 displayed 79.8%, 84%,
88%, and 82% amino acid identities with the respective homo-
logues of E. aerogenes (21) and showed similar levels of simi-
larity with the homologues of other Enterobacteriaceae.
It should be noted that PCR experiments carried out with
oligonucleotides designed on the acrR gene of E. aerogenes and
hybridization studies with the full acrR gene of E. aerogenes as
the probe failed to amplify the acrR gene. We therefore de-
cided to amplify a region upstream of the putative location of
the acrR gene on the genome map of E. aerogenes. For this
purpose, we designed a forward oligonucleotide based on a
consensus region of the aefA gene, which in turn was designed
on the basis of that of E. aerogenes and the recently released
genome of Enterobacter spp. (accession no. CP000653). Am-
plification experiments with the aefA-F and acrA2-R primers
(Table 2) yielded an amplicon of ca. 1,600 bp containing the
entire acrR gene from E. cloacae and the partial coding region
of aefA. The acrR gene of E. cloacae showed 73.9% nucleotide
identity with that of E. aerogenes (21), notably lower than that
observed for the acrA and acrB genes, which might account for
the negative results obtained with the initial approach.
Assembling the sequence of the entire locus revealed an
organization similar to that described for E. aerogenes (21),
with the 22-bp acrA-acrB intergenic sequence (amplified with
primers acrA3 and acrB2 [Table 2]) identical to that of E.
aerogenes. The acrR and acrA genes are also transcribed diver-
gently, and in the upstream acrA region, a 141-bp acrR-acrA
intergenic sequence showed the same acrA and acrR promoter
boxes previously found in E. aerogenes (GenBank accession no.
AJ306389). Indeed, by RT-PCR, high levels of acrR and acrA
gene expression were detected for EcDC64 compared to what
was found for E. cloacae JC 194 (data not shown).
Construction of the EcacrA strain. To investigate the role
of the AcrAB-TolC efflux pump in drug resistance, an acrA
knockout of EcDC64 was constructed (Ec
acrA) by replacing
part of the acrA gene with a kanamycin resistance cassette. The
knockout of acrA was confirmed by PCR mapping as described
in Materials and Methods (data not shown). RT-PCR results
confirmed that no acrA expression was detectable in Ec
acrA
(Table 3). When the Ec
acrA strain was transformed with
pAP-2, RT-PCR analysis showed that the acrA expression was
restored by complementation (Table 3).
Involvement of the AcrAB-TolC efflux pump in MDR. Suscep-
tibility testing was carried out with EcDC64 (with and without
PAN), Ec
acrA (with and without PAN), Ec
acrA(pAP-2),
Ec
acrA(pACYC184), EcDC64(pAP-3), and EcDC64(pBGS18)
(Tables 4, 5, and 6).
The efflux pump inhibitor PAN affected the MICs of and
susceptibilities to several antibiotics tested, revealing the pres-
ence of active drug efflux in EcDC64.
Analysis of the Ec
acrA mutant revealed an antibiotic sus-
ceptibility profile similar to that of EcDC64 in the presence of
PAN, with some exceptions (Tables 4 and 5). The data sug-
gest that other efflux systems in addition to AcrAB-TolC op-
erate in E. cloacae EcDC64. In this regard, the clearest result
was that obtained with fusidic acid (Table 5). It appears that
the AcrAB-TolC efflux system in E. cloacae does not pump out
fusidic acid, unlike what is seen for other species of Enterobac-
teriaceae (19, 27).
Concerning the various antibiotics, -lactam MICs were al-
most unaffected in Ec
acrA, with some exceptions (Table 4).
The MICs of erythromycin and clindamycin were dramatically
reduced in the knockout acrA mutant, as were those of tetra-
cycline, chloramphenicol, and linezolid, while there were mod-
est decreases in the MICs of aminoglycosides, ciprofloxacin,
tigecycline, and trimethoprim-sulfamethoxazole. Susceptibility
to telithromycin, novobiocin, nalidixic acid, norfloxacin, and
rifampin was also increased in Ec
acrA. Antibiotic resistance
was almost fully restored when the AcrA polypeptide was over-
expressed in Ec
acrA (Tables 4 and 5).
On the other hand, the antimicrobial susceptibility of
Ec
acrA further increased (in some cases dramatically) in the
presence of PAN, which points to the role of additional efflux
systems.
Analysis of the antibiotic susceptibility pattern and MICs of
EcDC64(pAP-3) revealed low MICs and large inhibition zones
with most antimicrobial agents and other compounds studied
compared to those for EcDC64 (Tables4,5, and 6). However,
the effect was lower than that obtained with Ec
acrA, a fact
which may be associated with the higher levels of expression of
the acrA gene in EcDC64(pAP-3) than in Ec
acrA (Table 3).
These results could be explained regarding the role of AcrR as
a specific secondary modulator to fine-tune the level of acrAB
transcription (13).
Analysis of detergents and dyes revealed lower MICs of most
of them for the acrA knockout mutant than for its isogenic pa-
rental strain. The MICs of detergents and dyes indicated that the
AcrAB-TolC efflux system is efficient at removing these products,
with the exception of Triton X-100 (Table 6).
acrA detection in several E. cloacae isolates. The acrA gene
was detected by PCR in six genetically unrelated E. cloacae iso-
lates used in the study (data not shown). This strongly suggests
that the AcrAB-TolC efflux pump is resident in the species.
Other antibiotic resistance mechanisms in E. cloacae
EcDC64. To analyze the involvement of efflux pumps in MDR
in EcDC64, the intrinsic background of antibiotic resistance
mechanisms that may act synergistically with efflux pumps must
also be taken into account. EcDC64 showed a broad spectrum
TABLE 3. RT-PCR analysis of ompC, ompF, and
acrA gene expression
Gene Strain Relative expressiona
ompF E. cloacae JC 194 1
EcDC64 0.2032
Ec
acrA 0.1931
ompC E. cloacae JC 194 1
EcDC64 0.00235
Ec
acrA 0.00252
acrA E. cloacae JC 194 1
EcDC64 490
Ec
acrA 0.002
Ec
acrA(pAP-2) 1,000
EcDC64(pAP-3) 300
a Relative expression is calculated as 2
CT, where 
CT is the ratio of the
crossing point target value to the crossing point reference value. The target is the
indicated bacterial isolate, whereas the reference is in all cases E. cloacae JC 194.
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of antibiotic resistance, with high-level resistance to -lactams
(including imipenem and meropenem). It has previously been
reported that the interplay between AmpC expression and the
reduction of porin expression may have an important role in
-lactam (including carbapenem) resistance in E. cloacae (10).
We therefore aimed to determine if this was also true for the
EcDC64 clinical isolate.
MICs for EcDC64 and for EcDC64 transformed with the
ampD gene from E. coli were determined as well as for
EcDC64 in the presence of cloxacillin. In both cases, there was
a dramatic reduction in some -lactam MICs (amoxicillin-
clavulanic acid, most of the cephalosporins, and carbapenems),
and indeed the MICs of imipenem and meropenem decreased
from 32 to 2 and from 32 to 0.75 g/ml, respectively. We
also aimed to determine whether or not a reduction of the
expression of ompC and ompF genes occurred in EcDC64.
Real-time RT-PCR enabled comparison of the levels of ex-
pression of ompC and ompF genes in the EcDC64 strain and in
the carbapenem-susceptible E. cloacae JC 194. Overall, the
results showed that the level of expression of ompC was ex-
tremely low and that the level of expression of ompF was also
lower than that seen for strain JC 194 (Table 3). Altogether,
the above results confirmed that AmpC overexpression and
decreased porin expression were also present as resistance
mechanisms in EcDC64.
Concluding remarks. The involvement of efflux mediated by
the AcrAB-TolC system in the decreased susceptibility to sev-
eral antibiotics of EcDC64 was demonstrated by different ap-
TABLE 4. Antibiotic susceptibility profiles (MICs) for the indicated bacterial isolates
Antibiotica
MIC (g/ml) for:
EcDC64 EcDC64 PANb Ec
acrA
Ec
acrA 
PANb Ec
acrA(pAP-2) Ec
acrA(pACYC184) EcDC64(pAP-3) EcDC64(pBGS18)
AMP 256 256 256 256 256 256 256 256
PEN 256 256 256 256 256 256 256 256
AMC 256 256 256 256 256 256 256 256
PIP 256 192 192 6 256 256 96 256
CEF 256 256 256 256 256 256 256 256
FOX 256 256 256 256 256 256 256 256
CXM 256 256 256 48 256 256 256 256
CAZ 256 256 256 16 256 256 256 256
CTX 256 256 256 8 256 256 256 256
IPM 32 32 24 6 32 32 24 32
MEM 32 32 24 1 32 32 24 32
ATM 256 64 64 2 256 128 64 256
OXA 256 48 96 4 256 256 256 256
ERY 256 1 12 0.094 128 16 48 256
CLI 256 6 2 1 256 4 32 256
TET 256 64 64 1.5 256 64 192 256
CHL 8 0.25 0.5 0.047 256 256 1 8
TOB 1.5 0.5 0.125 0.047 1.5 0.25 0.38 1
GEN 1.5 0.5 0.125 0.094 1 0.125 0.25 1
AMK 2 1.5 0.5 0.125 2 0.5 1 2
CIP 0.047 0.006 0.003 0.002 0.094 0.004 0.003 0.032
TGC 0.75 0.125 0.125 0.064 0.75 0.5 0.19 0.38
LZD 256 4 8 0.5 256 4 256 256
SXT 0.125 0.094 0.012 0.032 0.75 0.016 0.064 0.094
a Abbreviations for antibiotics: AMP, ampicillin; PEN, penicillin; AMC, amoxicillin-clavulanic acid; PIP, piperacillin; CEF, cephalothin; FOX, cefoxitin; CXM,
cefuroxime; CAZ, ceftazidime; CTX, cefotaxime; ATM, aztreonam; IPM, imipenem; MEM, meropenem; OXA, oxacillin; ERY, erythromycin; CLI, clindamycin; TET,
tetracycline; CHL, chloramphenicol; TOB, tobramycin; GEN, gentamicin; AMK, amikacin; CIP, ciprofloxacin; TGC, tigecycline; LZD, linezolid; SXT, trimethoprim-
sulfamethoxazole.
b MICs were determined with PAN at 20 g/ml.
TABLE 5. Antibiotic susceptibility profiles, expressed as diameters of the inhibition zones (in mm) determined by the standard disk diffusion
method, for the indicated bacterial isolates
Antibiotica
Susceptibility profile (diameter of inhibition zone in mm) for:
EcDC64 EcDC64 PANb Ec
acrA
Ec
acrA 
PANb Ec
acrA(pAP-2) Ec
acrA(pACYC184) EcDC64(pAP-3) EcDC64(pBGS18)
TEL 9 32 19 34 13 18 12 10
FUS 0 40 0 26 0 0 0 0
NOV 0 20 16 22 0 14 0 0
NAL 24 27 33 40 12 30 29 21
RIF 0 26 13 28 0 8 10 10
NOR 26 40 40 42 24 38 35 27
a Abbreviations for antibiotics: TEL, telithromycin; FUS, fusidic acid; NOV, novobiocin; NAL, nalidixic acid; RIF, rifampin; NOR, norfloxacin.
b Concentration of PAN, 20 g/ml.
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proaches. First, the MICs in the presence of the efflux pump
inhibitor PAN (20 g/ml) significantly increased the suscep-
tibility with respect to that of the wild-type strain. Second,
knockout of the acrA gene increased susceptibility to many of
the same compounds, although there were some differences
which suggested the role of additional efflux systems. Third,
transformation of EcDC64 with the acrR gene from E. aero-
genes also reduced the MICs of most of the same antibiotics.
The role of the efflux pump in -lactam resistance has not
been clearly elucidated because the host strain used in the
present study bears a class C -lactamase in its chromosome,
overexpression of which affects most -lactams. However,
there was a decrease in piperacillin, aztreonam, oxacillin, and
carbapenem MICs when either the EcDC64 strain with
PAN or MICs in the Ec
acrA strain were analyzed.
The role of AcrAB-TolC-type efflux pumps in macrolide and
quinolone resistance has previously been described for some
species of Enterobacteriaceae as a major mechanism of resis-
tance (1, 9, 11, 15, 16, 19, 21). A macrolide-specific ABC-type
transporter was recently reported for E. coli (8). This efflux
system may also operate in the clinical isolate under study,
which would explain the difference between the MIC of eryth-
romycin for EcDC64 with PAN and that for Ec
acrA (from
256 to 1 and 12 g/ml, respectively).
It is noteworthy that this mechanism may at least partly
explain the “intrinsic” resistance of Enterobacter to some anti-
biotics used to treat gram-positive infections, such as oxacillin,
linezolid, clindamycin, fusidic acid, novobiocin, and rifampin,
although another efflux pump is probably involved in resistance
to fusidic acid. In this regard, it has been demonstrated that the
intracellular concentration of linezolid in strains of E. coli, E.
aerogenes, and Citrobacter freundii is comparatively low due to
the efficient efflux of the drug by the resistance-nodulation-
division-type efflux pump (25).
Unlike the AcrAB-TolC efflux pump from E. aerogenes (5),
which does not appear to pump out telithromycin, the clinical
isolate EcDC64 increased the inhibition zone for this antibiotic
(from 9 to 19 mm) when the acrA gene was deleted. As with E.
aerogenes, a more dramatic effect was observed when MICs of
EcDC64 were determined in the presence of an efflux pump
inhibitor (PAN) (Table 5).
As for the clinical isolate under study, the AcrAB efflux
pumps in Proteus mirabilis and Klebsiella pneumoniae have
been associated with decreased susceptibility to tigecycline (23,
28), although in the present case the increase in susceptibility
in the acrA knockout isolate was lower (the knockout strain
MIC was sixfold lower than that for the parental strain). It is
interesting that Keeney et al. (7) have recently reported the
involvement of AcrAB of E. cloacae in decreased susceptibility
to tigecycline, although the values reported (16- to 32-fold
reductions) are higher than those we have described here.
These differences may be related to the level of AcrAB-TolC
gene expression in the strains under study.
ACKNOWLEDGMENTS
Margarita Poza is a receipt of an Isidro Parga Pondal research contract,
Alejandro Beceiro of a scholarship from SEIMC, and Marı´a del Mar
Toma´s of a postMIR research contract from the Instituto de Salud Carlos
III. The study was partly financed by the Consellerı´a de Innovacio´n,
Industria y Comercio, Xunta de Galicia (PGIDIT04BTF916028PR),
Fondo de Investigaciones Sanitarias (PI040514 and PI061368), and also
supported by Ministerio de Sanidad y Consumo, ISCIII, Spanish Network
for the Research in Infectious Diseases (REIPI RD06/0008).
We thank I. Rego for technical assistance in RT-PCR experiments.
REFERENCES
1. Baucheron, S., S. Tyler, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla, and A.
Cloeckaert. 2004. AcrAB-TolC directs efflux-mediated multidrug resistance
in Salmonella enterica serovar Typhimurium DT104. Antimicrob. Agents
Chemother. 48:3729–3735.
2. Berlanga, M., J. L. Vazquez, J. Hernandez-Borrell, M. T. Montero, and M.
Vinas. 2000. Evidence of an efflux pump in Serratia marcescens. Microb. Drug
Resist. 6:111–117.
2a.Canle, D., M. Cartelle, C. Latasa, I. Lasa, R. Villanueva, and G. Bou. 2005.
Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-1035.
3. Chang, A. C. Y., and S. N. Cohen. 1978. Construction and characterization of
amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic
miniplasmid. J. Bacteriol. 134:1141–1156.
4. Chaveroche, M. K., J. M. Ghigo, and C. d’Enfert. 2000. A rapid method for
efficient gene replacement in the filamentous fungus Aspergillus nidulans.
Nucleic Acids Res. 28:e97.
5. Chollet, R., J. Chevalier, A. Bryskier, and J. M. Pages. 2004. The AcrAB-
TolC is involved in macrolide resistance but not in telithromycin efflux in
Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother.
48:3621–3624.
6. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromo-
somal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad.
Sci. USA 97:6640–6645.
7. Keeney, D., A. Ruzin, and P. A. Bradford. 2007. RamA, a transcriptional
regulator, and AcrAB, an RND-type efflux pump, are associated with de-
creased susceptibility to tigecycline in Enterobacter cloacae. Microb. Drug
Resist. 13:1–6.
8. Kobayashi, N., K. Nishino, and A. Yamaguchi. 2001. Novel macrolide-spe-
cific ABC-type efflux transporter in Escherichia coli. J. Bacteriol. 183:5639–
5644.
9. Kumar, A., and E. A. Worobec. 2002. Fluoroquinolone resistance of Serratia
marcescens: involvement of a proton gradient-dependent efflux pump. J.
Antimicrob. Chemother. 50:593–596.
10. Lee, E. H., E. Collatz, J. Trias, and L. Gutmann. 1992. Diffusion of beta-
lactam antibiotics into proteoliposomes reconstituted with outer membranes
of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae.
J. Gen. Microbiol. 138:2347–2351.
11. Linde, H. J., F. Notka, C. Irtenkauf, J. Decker, J. Wild, H. H. Niller, P.
Heisig, and N. Lehn. 2002. Increase in MICs of ciprofloxacin in vivo in two
closely related clinical isolates of Enterobacter cloacae. J. Antimicrob. Che-
mother. 49:625–630.
TABLE 6. MICs of detergents and dyes for bacterial isolates
Compound
MIC (g/ml) for:
EcDC64 Ec
acrA Ec
acrA(pAP-2) Ec
acrA(pACYC184) EcDC64(pAP-3) EcDC64(pBGS18)
Sodium dodecyl sulfate 8,192 256 4,096 128 1,024 8,192
Sodium deoxycholate 8,192 256 4,096 256 512 8,192
Sodium cholate 16,384 2,048 16,384 2,048 4,096 16,384
Triton X-100 16,384 16,384 16,384 16,384 16,384 16,384
Acriflavine 128 16 64 16 32 128
Crystal violet 4,096 512 1,024 256 1,024 4,096
Ethidium bromide 2,048 128 1,024 64 256 2,048
3252 PE´REZ ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 o
n
 January 4, 2019 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
12. Linde, H. J., F. Notka, M. Metz, B. Kochanowski, P. Heisig, and N. Lehn.
2000. In vivo increase in resistance to ciprofloxacin in Escherichia coli asso-
ciated with deletion of the C-terminal part of MarR. Antimicrob. Agents
Chemother. 44:1865–1868.
13. Ma, D., M. Alberti, C. Lynch, H. Nikaido, and J. E. Hearst. 1996. The local
repressor AcrR plays a modulating role in the regulation of acrAB genes of
Escherichia coli by global stress signals. Mol. Microbiol. 19:101–112.
14. Mallea, M., J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet,
and J. M. Pages. 1998. Porin alteration and active efflux: two in vivo drug
resistance strategies used by Enterobacter aerogenes. Microbiology 144:3003–
3009.
15. Mazzariol, A., J. Zuliani, G. Cornaglia, G. M. Rossolini, and R. Fontana.
2002. AcrAB efflux system: expression and contribution to fluoroquinolone
resistance in Klebsiella spp. Antimicrob. Agents Chemother. 46:3984–3986.
16. Mazzariol, A., Y. Tokue, T. M. Kanegawa, G. Cornaglia, and H. Nikaido.
2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli
overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother.
44:3441–3443.
17. Nikaido, H. 1998. Antibiotic resistance caused by gram-negative multidrug
efflux pumps. Clin. Infect. Dis. 27:32–41.
18. Nikaido, H., and H. I. Zgurskaya. 1999. Antibiotic efflux mechanisms. Curr.
Opin. Infect. Dis. 12:529–536.
19. Nikaido, H., M. Basina, V. Nguyen, and E. Y. Rosenberg. 1998. Multidrug
efflux pump AcrAB of Salmonella typhimurium excretes only those -lactam
antibiotics containing lipophilic side chains. J. Bacteriol. 180:4686–4692.
20. Poole, K. 2004. Efflux-mediated multiresistance in Gram-negative bacteria.
Clin. Microbiol. Infect. 10:12–26.
21. Pradel, E., and J. M. Pages. 2002. The AcrAB-TolC efflux pump contributes
to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes.
Antimicrob. Agents Chemother. 46:2640–2643.
22. Rose, R. E. 1988. The nucleotide sequence of pACYC184. Nucleic Acids
Res. 16:355.
23. Ruzin, A., M. A. Visalli, D. Keeney, and P. A. Bradford. 2005. Influence
of transcriptional activator RamA on expression of multidrug efflux pump
AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob.
Agents Chemother. 49:1017–1022.
24. Sanders, W. E., and C. C. Sanders. 1997. Enterobacter spp.: pathogens poised
to flourish at the turn of the century. Clin. Microbiol. Rev. 10:220–241.
25. Schumacher, A., R. Trittler, J. A. Bohnert, K. Kummerer, J. M. Pages, and
W. V. Kern. 2007. Intracellular accumulation of linezolid in Escherichia coli,
Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump
activity and inactivation. J. Antimicrob. Chemother. 59:1261–1264.
26. Spratt, B., P. J. Hedge, T. S. Heesen, A. Edelman, and J. K. Broome-Smith.
1986. Kanamycin-resistant vectors that are analogues of plasmids pUC8,
pUC9, pEMBL8, and pEMBL9. Gene 41:337–342.
27. Sulavik, M. C., C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene,
B. DiDomenico, K. J. Shaw, G. H. Miller, R. Hare, and G. Shimer. 2001.
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug
efflux pump genes. Antimicrob. Agents Chemother. 45:1126–1136.
28. Visalli, M. A., E. Murphy, S. J. Projan, and P. A. Bradford. 2003. AcrAB
multidrug efflux pump is associated with reduced levels of susceptibility to
tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother.
47:665–669.
VOL. 51, 2007 AcrAB-TolC EFFLUX PUMP OF E. CLOACAE 3253
 o
n
 January 4, 2019 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
